Dashboard
Manage Tickers

CRL CHARLES RIVER LABORATORIES ...

NYSE criver.com


$ 173.54 $ 3.80 (2.24 %)    

Tuesday, 11-Nov-2025 15:59:59 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 622.00 $ 0.90 (0.15 %)
DIA $ 479.80 $ 5.34 (1.13 %)
SPY $ 683.25 $ 2.90 (0.43 %)
TLT $ 89.96 $ 0.01 (0.01 %)
GLD $ 379.85 $ -0.09 (-0.02 %)
$ 168.97
$ 169.53
$ 172.05 x 45
$ 179.00 x 40
$ 167.67 - $ 175.39
$ 91.86 - $ 222.10
1,163,791
na
8.32B
$ 1.18
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-27-2025 10-Q
2 08-06-2025 06-28-2025 10-Q
3 05-07-2025 03-29-2025 10-Q
4 02-19-2025 12-28-2024 10-K
5 11-06-2024 09-28-2024 10-Q
6 08-07-2024 06-29-2024 10-Q
7 05-09-2024 03-30-2024 10-Q
8 02-14-2024 12-30-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-09-2023 07-01-2023 10-Q
11 05-11-2023 04-01-2023 10-Q
12 02-22-2023 12-31-2022 10-K
13 11-02-2022 09-24-2022 10-Q
14 08-03-2022 06-25-2022 10-Q
15 05-04-2022 03-26-2022 10-Q
16 02-16-2022 12-25-2021 10-K
17 11-03-2021 09-25-2021 10-Q
18 08-04-2021 06-26-2021 10-Q
19 05-04-2021 03-27-2021 10-Q
20 02-17-2021 12-26-2020 10-K
21 11-09-2020 09-26-2020 10-Q
22 10-29-2020 09-26-2020 10-Q
23 08-05-2020 06-27-2020 10-Q
24 05-07-2020 03-28-2020 10-Q
25 02-11-2020 12-28-2019 10-K
26 11-06-2019 09-28-2019 10-Q
27 07-31-2019 06-29-2019 10-Q
28 05-07-2019 03-30-2019 10-Q
29 02-13-2019 12-29-2018 10-K
30 11-07-2018 09-29-2018 10-Q
31 08-08-2018 06-30-2018 10-Q
32 05-10-2018 03-31-2018 10-Q
33 02-13-2018 12-30-2017 10-K
34 11-09-2017 09-30-2017 10-Q
35 08-09-2017 07-01-2017 10-Q
36 05-10-2017 04-01-2017 10-Q
37 02-14-2017 12-31-2016 10-K
38 11-02-2016 09-24-2016 10-Q
39 08-03-2016 06-25-2016 10-Q
40 05-04-2016 03-26-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

morgan-stanley-maintains-equal-weight-on-charles-river-raises-price-target-to-185
Morgan Stanley Maintains Equal-Weight on C...
11/11/2025 16:36:23

Morgan Stanley analyst Ricky Goldwasser maintains Charles River (NYSE:CRL) with a Equal-Weight and raises the price target f...

td-cowen-maintains-buy-on-charles-river-lowers-price-target-to-197
TD Cowen Maintains Buy on Charles River, L...
11/10/2025 17:29:10

TD Cowen analyst Charles Rhyee maintains Charles River (NYSE:CRL) with a Buy and lowers the price target from $205 to $197.

jp-morgan-maintains-neutral-on-charles-river-raises-price-target-to-165
JP Morgan Maintains Neutral on Charles Riv...
11/06/2025 21:41:44

JP Morgan analyst Casey Woodring maintains Charles River (NYSE:CRL) with a Neutral and raises the price target from $160 to ...

barclays-maintains-overweight-on-charles-river-raises-price-target-to-210
Barclays Maintains Overweight on Charles R...
11/06/2025 14:31:38

Barclays analyst Luke Sergott maintains Charles River (NYSE:CRL) with a Overweight and raises the price target from $195 to ...

this-charles-river-laboratories-analyst-turns-bullish-here-are-top-5-upgrades-for-thursday
This Charles River Laboratories Analyst Tu...
11/06/2025 12:48:43

robinhood-to-rally-more-than-20-here-are-10-top-analyst-forecasts-for-thursday
Robinhood To Rally More Than 20%? Here Are...
11/06/2025 12:41:06

baird-upgrades-charles-river-to-outperform-raises-price-target-to-199
Baird Upgrades Charles River to Outperform...
11/06/2025 11:49:36

Baird analyst Eric Coldwell upgrades Charles River (NYSE:CRL) from Neutral to Outperform and raises the price target from $1...

charles-river-beat-expectations-but-why-is-the-stock-falling
Charles River Beat Expectations But Why Is...
11/05/2025 18:38:50

Charles River stock dips as Q3 revenue slips, EPS beats estimates, and company raises 2025 outlook with cost cuts and $1 billio...

charles-river-raises-fy2025-adj-eps-guidance-from-990-1030-to-1010-1030-vs-1019-est-lowers-fy2025-sales-guidance-from-3949b-4030b-to-3848b-3989b-vs-3991b-est
Charles River Raises FY2025 Adj EPS Guidan...
11/05/2025 12:09:07

The Company's 2025 guidance for revenue and earnings per share is as follows:2025 GUIDANCECURRENTPRIORRevenue growth/(decre...

charles-river-lowers-fy2025-gaap-eps-guidance-from-425-465-to-415-435-vs-457-est
Charles River Lowers FY2025 GAAP EPS Guida...
11/05/2025 12:08:20

The Company's 2025 guidance for revenue and earnings per share is as follows:2025 GUIDANCECURRENTPRIORRevenue growth/(decre...

charles-river-laboratories-expects-to-sell-certain-non-core-businesses-to-focus-on-more-profitable-growth-opportunities-representing-7-of-2025-estimated-revenue-the-proposed-divestitures-are-expected-to-result-in-adj-eps-accretion-of-at-least-030-on-an-annualized-basis
Charles River Laboratories Expects To Sell...
11/05/2025 12:05:00

charles-river-q3-adj-eps-243-beats-234-estimate-sales-1005b-beat-990769m-estimate
Charles River Q3 Adj. EPS $2.43 Beats $2.3...
11/05/2025 12:00:50

earnings-scheduled-for-november-5-2025
Earnings Scheduled For November 5, 2025
11/05/2025 11:12:12

charles-river-laboratories-and-the-francis-crick-institute-enters-collaboration-to-advance-antibody-drug-conjugate-drug-discovery-and-development
Charles River Laboratories And The Francis...
10/22/2025 12:02:18

Charles River Laboratories International, Inc. (NYSE:CRL) and The Francis Crick Institute (Crick) today announced a new collabo...

charles-river-announces-strategic-collaboration-with-x-chem-to-enhance-hit-identification-capabilities-and-accelerate-discovery-of-novel-therapeutics
Charles River Announces Strategic Collabor...
10/20/2025 12:08:51

X-Chem's DNA-encoded library complements Charles River's discovery expertise to accelerate hit identificationCharles Ri...

mizuho-maintains-neutral-on-charles-river-raises-price-target-to-174
Mizuho Maintains Neutral on Charles River,...
10/17/2025 13:17:40

Mizuho analyst Ann Hynes maintains Charles River (NYSE:CRL) with a Neutral and raises the price target from $155 to $174.

earlier-today-charles-river-and-toxys-collaborate-to-offer-reprotracker-assay-for-rapid-developmental-toxicity-testing
Earlier Today: Charles River And Toxys Col...
10/08/2025 14:14:49

Charles River Laboratories International, Inc. (NYSE:CRL) and Toxys today announced a collaboration that offers Charles River&#...

why-charles-river-stock-may-struggle-in-its-final-phase
Why Charles River Stock May Struggle In It...
10/07/2025 11:22:54

Adhishthana.com notes Charles River Stock is nearing its Phase 18, with momentum weakening and long-term outperformance looking...

william-blair-upgrades-charles-river-to-outperform
William Blair Upgrades Charles River to Ou...
10/06/2025 15:27:44

William Blair analyst Matt Larew upgrades Charles River (NYSE:CRL) from Market Perform to Outperform.

evercore-isi-group-maintains-outperform-on-charles-river-raises-price-target-to-200
Evercore ISI Group Maintains Outperform on...
10/03/2025 15:58:24

Evercore ISI Group analyst Ross Muken maintains Charles River (NYSE:CRL) with a Outperform and raises the price target from ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION